Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Avalo Therapeutics Inc., 2 years.
Avalo Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 1, 2026 | REGENXBIO Inc. | Grant or award | +24,305 | — | — |
| Sep 1, 2026 | REGENXBIO Inc. | Shares withheld for tax | −4,902 | $9.32 | $45,687 |
| May 6, 2026 | Avalo Therapeutics Inc. | Open-market sale | −3,167 | $22.88 | $72,461 |
| Mar 28, 2026 | Avalo Therapeutics Inc. | Option exercise | +3,166 | — | — |
| Jan 6, 2026 | REGENXBIO Inc. | Grant or award | +73,749 | — | — |
| Sep 1, 2025 | REGENXBIO Inc. | Shares withheld for tax | −4,901 | $8.93 | $43,766 |
| Mar 28, 2025 | Avalo Therapeutics Inc. | Option exercise | +3,167 | — | — |
| Sep 16, 2024 | REGENXBIO Inc. | Grant or award | +58,869 | — | — |
Questions about Mitchell Chan
What boards is Mitchell Chan on?
Mitchell Chan sits on the board of Avalo Therapeutics Inc.
How long has Mitchell Chan served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.